{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:31:56Z","timestamp":1791322316329,"version":"4.3.1"},"reference-count":18,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,2,13]],"date-time":"2012-02-13T00:00:00Z","timestamp":1329091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To examine the prevalence of sicca symptoms and secondary <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>j\u00f6gren's syndrome (<jats:styled-content style=\"fixed-case\">sSS<\/jats:styled-content>) in rheumatoid arthritis (<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>) patients, and the impact of <jats:styled-content style=\"fixed-case\">sSS<\/jats:styled-content> on disease activity and treatment profile in <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Three hundred and seven <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients responding positive to at least one of the questions in a questionnaire about sicca symptoms, were examined by <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>chirmer <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content> test for tear production, and unstimulated whole saliva collection (<jats:styled-content style=\"fixed-case\">USWC<\/jats:styled-content>). Secondary <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>j\u00f6gren's syndrome was defined by at least one subjective sicca symptom, in addition to a positive <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>chirmer <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content> test and positive <jats:styled-content style=\"fixed-case\">USWC<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 307 <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients, 86 (28%) responded positive to at least one question about sicca symptoms, and 11 patients were positive for both <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>chirmer <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">USWC<\/jats:styled-content> tests, giving a minimum prevalence of <jats:styled-content style=\"fixed-case\">sSS<\/jats:styled-content> at 3.6%. There were no differences in <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients with and without <jats:styled-content style=\"fixed-case\">sSS<\/jats:styled-content> regarding age, sex, disease duration, disease activity score (<jats:styled-content style=\"fixed-case\">DAS<\/jats:styled-content>\u201028) and seropositivity for anti\u2010cyclic citrullinated protein. <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients with <jats:styled-content style=\"fixed-case\">sSS<\/jats:styled-content> had a tendency for higher numbers of tender and swollen joints and pain. None of the <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients treated with tumor necrosis factor (<jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>) inhibitors had <jats:styled-content style=\"fixed-case\">sSS<\/jats:styled-content>, compared to 22% of the rest of the <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> population studied. The treatment of the <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients with and without <jats:styled-content style=\"fixed-case\">sSS<\/jats:styled-content> was not different.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Among the 307 <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients, 28% had at least one sicca symptom. The estimated minimum of prevalence of <jats:styled-content style=\"fixed-case\">sSS<\/jats:styled-content> in 307 <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients was 3.6%. Secondary <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>j\u00f6gren's syndrome was not found in <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients treated with biologics such as <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content> blockers.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1756-185x.2012.01717.x","type":"journal-article","created":{"date-parts":[[2012,2,13]],"date-time":"2012-02-13T08:07:25Z","timestamp":1329120445000},"page":"284-288","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["A study of the prevalence of sicca symptoms and secondary <scp>S<\/scp>j\u00f6gren's syndrome in patients with rheumatoid arthritis, and its association to disease activity and treatment profile"],"prefix":"10.1111","volume":"15","author":[{"given":"Hans\u2010Jacob","family":"Haga","sequence":"first","affiliation":[{"name":"Aalborg University Esbjerg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Naderi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Sydvestjysk Sygehus Esbjerg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia Martin","family":"Moreno","sequence":"additional","affiliation":[{"name":"Department of Urology The National Hospital Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Peen","sequence":"additional","affiliation":[{"name":"Aalborg University Esbjerg"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,2,13]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"1736","volume-title":"Arthritis and Allied Conditions. A Textbook of Rheumalology","author":"Jonsson R","year":"2001"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.029066"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.9.897"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2007.05.007"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.58.7.415"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1563-2571.2002.01043.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018472213872"},{"key":"e_1_2_7_9_1","first-page":"1296","article-title":"Survivorship in a population based cohort of patients with Sj\u00f6gren's syndrome 1976\u20131992","volume":"26","author":"Martens PB","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_7_10_1","first-page":"62","article-title":"Occurrence of extra\u2010articular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis","volume":"29","author":"Turesson C","year":"2002","journal-title":"J Rheumatol"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10999"},{"key":"e_1_2_7_13_1","first-page":"604","article-title":"The sensitivity and reliability of diagnostic tests for primary Sj\u00f6gren's syndrome","volume":"26","author":"Haga H\u2010J","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.6.554"},{"key":"e_1_2_7_15_1","first-page":"305","article-title":"Extra\u2010articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey","volume":"24","author":"Calg\u00fcneri M","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_16_1","first-page":"1098","article-title":"Sj\u00f6gren syndrome in rheumatoid arthritis","volume":"14","author":"Andonopoulos A","year":"1987","journal-title":"J Rheumatol"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350705"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.10.1085"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.6.603"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1756-185X.2012.01717.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1756-185X.2012.01717.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T17:22:17Z","timestamp":1698772937000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1756-185X.2012.01717.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,13]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1111\/j.1756-185X.2012.01717.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1756-185x.2012.01717.x","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,13]]},"assertion":[{"value":"2012-02-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}